165 related articles for article (PubMed ID: 37083273)
1. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
[TBL] [Abstract][Full Text] [Related]
2. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
[TBL] [Abstract][Full Text] [Related]
4. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
[TBL] [Abstract][Full Text] [Related]
5. Incidence, demographic characteristics, and geographic distribution of sickle cell trait and sickle cell anemia births in Michigan, 1997-2014.
Reeves SL; Jary HK; Gondhi JP; Kleyn M; Spector-Bagdady K; Dombkowski KJ
Mol Genet Genomic Med; 2019 Aug; 7(8):e795. PubMed ID: 31210022
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
O'Leary JD; Odame I; Pehora C; Chakraborty P; Crawford MW
Can J Anaesth; 2013 Jan; 60(1):54-9. PubMed ID: 23104576
[TBL] [Abstract][Full Text] [Related]
7. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
8. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
11. Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.
Reeves SL; Jary HK; Gondhi JP; Kleyn M; Dombkowski KJ
Blood Adv; 2019 May; 3(10):1574-1580. PubMed ID: 31101648
[TBL] [Abstract][Full Text] [Related]
12. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
13. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
Hernandez AG; Kiyaga C; Howard TA; Ssewanyana I; Ndeezi G; Aceng JR; Ware RE
Trop Med Int Health; 2021 Jan; 26(1):23-32. PubMed ID: 33151598
[TBL] [Abstract][Full Text] [Related]
14. Incidence of hemoglobinopathies and spatialization of newborns with sickle cell trait in Mato Grosso do Sul, Brazil.
Cândido-Bacani PM; Grilo PMS; Ramos VDS; Zanchin M; Pereira IC; Oliveira JSP; Bacani VM; Belini Junior E
Einstein (Sao Paulo); 2022; 20():eAO6535. PubMed ID: 35584443
[TBL] [Abstract][Full Text] [Related]
15. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
[TBL] [Abstract][Full Text] [Related]
16. Community based screening for sickle haemoglobin among pregnant women in Benue State, Nigeria: I-Care-to-Know, a Healthy Beginning Initiative.
Ezenwosu OU; Itanyi IU; Nnodu OE; Ogidi AG; Mgbeahurike F; Ezeanolue EE
BMC Pregnancy Childbirth; 2021 Jul; 21(1):498. PubMed ID: 34238241
[TBL] [Abstract][Full Text] [Related]
17. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
Dave K; Desai S; Italia Y; Mukherjee MB; Mehta P; Desai G
Indian Pediatr; 2022 Mar; 59(3):230-233. PubMed ID: 35014619
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell trait diagnosis: clinical and social implications.
Naik RP; Haywood C
Hematology Am Soc Hematol Educ Program; 2015; 2015(1):160-7. PubMed ID: 26637716
[TBL] [Abstract][Full Text] [Related]
19. Newborn sickle cell screening in a region of Western New York State.
Lerner NB; Platania BL; LaBella S
J Pediatr; 2009 Jan; 154(1):121-5. PubMed ID: 18804215
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell trait and the potential risk of severe coronavirus disease 2019-A mini-review.
Kehinde TA; Osundiji MA
Eur J Haematol; 2020 Nov; 105(5):519-523. PubMed ID: 32589774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
